This HTML5 document contains 203 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n6http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q34742583
rdf:type
wikibase:Item
schema:description
2011 nî lūn-bûn teaduslik artikkel article científic naučni članak სამეცნიერო სტატია vitenskapelig artikkel 2011年论文 artículu científicu espublizáu en 2011 научни чланак tieteellinen artikkeli vetenskaplig artikel artigo científico articolo scientifico 2011 թուականի Յունուարին հրատարակուած գիտական յօդուած 2011年论文 article scientific artigo científico (publicado na 2011) מאמר מדעי บทความทางวิทยาศาสตร์ مقالهٔ علمی 2011년 논문 2011年論文 tudományos cikk سائنسی مضمون 2011年論文 artigo científico (publicado na 2011) مقالة علمية artikull shkencor научна статия 2011年の論文 2011年论文 artículo científico publicado en 2011 articol științific bài báo khoa học scienca artikolo 2011年论文 bilimsel makale мақолаи илмӣ научни чланак wetenschappelijk artikel videnskabelig artikel (udgivet 2011) vědecký článek 2011年論文 мақолаи илмӣ artykuł naukowy scientific article mokslinis straipsnis ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована в січні 2011 2011年论文 2011年論文 επιστημονικό άρθρο artikulong pang-agham научная статья vitskapeleg artikkel article scientifique (publié 2011) 2011 թվականի հունվարին հրատարակված գիտական հոդված 2011年論文 vedecký článok 2011年论文 wissenschaftlicher Artikel
p:P577
wds:Q34742583-B829B386-1576-4D2E-8785-AA83B564A931
wdt:P577
2011-01-26T00:00:00Z
p:P407
wds:Q34742583-961BD293-CB3F-4ADE-BE91-E26322BD3104
wdt:P407
wd:Q1860
p:P2860
wds:Q34742583-82A92D75-C974-4FF1-A3FF-8F993EEDE47A wds:Q34742583-8CD12615-50C5-4325-A677-47A95343D8BC wds:Q34742583-9B1814B6-A26F-4B4A-BEFF-E16317DDC281 wds:Q34742583-ADE3FF4A-5080-40EA-BDBD-E548C6D4C5D5 wds:Q34742583-C0F0A37B-CEDE-4EF0-9E74-8FDCB8C76530 wds:Q34742583-C612C14A-C7D5-4A4F-A1A7-35A07FA7F255 wds:Q34742583-D0914CF7-6FC9-4987-815E-EE2261D46D0B wds:Q34742583-D6D18D2E-5864-4E5D-AB2D-BD8BBB8B46D9 wds:Q34742583-DFD65198-E886-40E9-8428-BC0A558B0B5A wds:Q34742583-5447B941-F5BD-4715-AD0D-54607E9DA549 wds:Q34742583-54FE8DE9-9F80-4380-AB89-9337876BAEC4 wds:Q34742583-5A703769-4251-4249-BBA6-D560FCB740BB wds:Q34742583-6131DDE4-DB04-47C1-BFEA-BE4A2E452E35 wds:Q34742583-64046851-B110-44A4-B427-48E25E48260C wds:Q34742583-66E68530-B5A7-4852-923C-94A700BA7660 wds:Q34742583-6A23C5C5-97E8-427D-8D38-8E11839E20C2 wds:Q34742583-6A263665-6202-4A42-9695-E7D7EB83D26E wds:Q34742583-6D11687B-662A-46F5-9DA3-304F44B7E6B1 wds:Q34742583-6ED584BC-BDC7-43DB-B031-57F0D8F30252 wds:Q34742583-7CD08B96-C2B5-4410-A32D-4E58A64CF207 wds:Q34742583-7FB72C85-1A47-4A86-AC7C-618AFDE9EBD1 wds:Q34742583-0EC67C4B-A93E-4B81-B301-17B1DF58BACC wds:Q34742583-0F4DF05F-52A6-461D-9522-898C47FBDA2C wds:Q34742583-140A006D-D2E5-44DE-BFFC-E426036B1CA3 wds:Q34742583-140B4811-9E9E-4C10-89A0-94652F0BC168 wds:Q34742583-18B776B1-77F4-40CA-8153-E45981265999 wds:Q34742583-1BF05001-2DC0-4EF8-9E07-5B10B846572F wds:Q34742583-1E6E0294-514E-4E8A-A2C3-19C62E1A40EF wds:Q34742583-1FB677D6-503A-42A4-B0D6-683ECFD4A6AF wds:Q34742583-235B2742-CFE0-4F2B-91B4-C9B5858FA30C wds:Q34742583-2AD0BFD8-F732-4C56-A592-0ED1E194B4D5 wds:Q34742583-30B5AE16-6BDF-42CF-8832-346C4A5F9382 wds:Q34742583-337E1903-760A-499C-B7F6-1A53E8F52ADF wds:Q34742583-342216FA-1BF4-45DF-AAFB-994A8C47B8E4 wds:Q34742583-456824F9-6369-45A0-BD52-C9FC8E9FEF32 wds:Q34742583-495B09C6-D1F6-49F2-9C4D-3D5BD1D283FE wds:Q34742583-024E300F-26EF-4A01-ADA3-6E15C261127E wds:Q34742583-043EB92A-6F92-4D75-A121-5BBC78B022E8 wds:Q34742583-07DBE448-0A8A-44E2-B439-74382536321C wds:Q34742583-0CAEA3CC-CEDE-4EDD-9204-09DB7CEB5C90 wds:Q34742583-0E227313-AFD9-47F2-9402-97D19148DDBB wds:Q34742583-EC79AD40-9959-48F6-BBC7-9174961B8E13 wds:Q34742583-EF06B0D7-0D1A-4C29-9C72-0384A787A6A9 wds:Q34742583-F02DC985-8C84-4E89-8B16-68B936195DF7 wds:Q34742583-F29DC672-40EE-4328-B66E-6AED7859CF17 wds:Q34742583-F5BC3970-8355-4C23-9F88-29A76F5AE4B3 wds:Q34742583-F7233B48-312F-432E-871D-8F792C14D1F7 wds:Q34742583-F8A568A6-5081-42A0-997C-33FDC40B0293
wdt:P2860
wd:Q42028474 wd:Q45823697 wd:Q34470594 wd:Q37409686 wd:Q45740273 wd:Q36082625 wd:Q33782992 wd:Q45035531 wd:Q37295563 wd:Q57076537 wd:Q78082370 wd:Q22255627 wd:Q33810615 wd:Q36844715 wd:Q39966067 wd:Q24562414 wd:Q45763558 wd:Q36937380 wd:Q34111689 wd:Q36388158 wd:Q43763347 wd:Q37380356 wd:Q33783025 wd:Q36267182 wd:Q45759646 wd:Q45755360 wd:Q38313920 wd:Q44685720 wd:Q33753562 wd:Q37305719 wd:Q45740275 wd:Q41109409 wd:Q39782280 wd:Q35899978 wd:Q37746861 wd:Q35914513 wd:Q36570266 wd:Q33963713 wd:Q33820412 wd:Q33235520 wd:Q36402863 wd:Q36931089 wd:Q34177787 wd:Q36331074 wd:Q33551402 wd:Q36633084 wd:Q34338715 wd:Q45752846
p:P2093
wds:Q34742583-4FABF070-39E5-4DA1-9F00-3E6FC23A374C wds:Q34742583-7A7F3640-C373-48EB-964A-FA8EDC0D17DD wds:Q34742583-C5C022AB-CBDA-481B-90A8-25A10C92DEBD
wdt:P2093
Kimberly A Kraynyak Michael S Levinson Christopher S Morello
rdfs:label
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease Immunization with herpes simplex virus 2
skos:prefLabel
Immunization with herpes simplex virus 2 Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease
schema:name
Immunization with herpes simplex virus 2 Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease
p:P50
wds:Q34742583-0FAC7487-933E-4FE8-AD67-619D31A24DD6
wdt:P50
wd:Q41770283
p:P1476
wds:Q34742583-9ED41A2D-A606-4CD8-84E8-AE89F4A4E00E
wdt:P1476
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease
p:P304
wds:Q34742583-C6D4AA47-8860-4AC2-B9F9-DE9BC76B72D4
wdt:P304
3461-3472
p:P31
wds:Q34742583-49BCEDCE-5B3A-45CE-BF74-72E0993DD8CE
wdt:P31
wd:Q13442814
p:P921
wds:Q34742583-A0D87D62-76A0-450A-B13D-A9EFA7ED349A wds:Q34742583-FCB7546A-7103-47CF-8075-59E4DD9CF677
wdt:P921
wd:Q1415366 wd:Q18965147
p:P698
wds:Q34742583-EB785ABA-CC70-4F79-872B-A173135F5D8B
wdtn:P698
n11:21270160
wdt:P698
21270160
p:P1433
wds:Q34742583-E3E1E6B4-F4EA-4ECE-A2DD-0B319B14696E
wdt:P1433
wd:Q1251128
p:P433
wds:Q34742583-0946F874-F9EB-4EF0-A48F-638D6545E0BE
p:P478
wds:Q34742583-7446D200-A68E-4A3D-8B52-5F27F0345B0D
wdt:P433
7
wdt:P478
85
p:P356
wds:Q34742583-AB3ADA4C-429E-4716-9F3A-828C0E523A81
wdtn:P356
n6:JVI.02521-10
wdt:P356
10.1128/JVI.02521-10
p:P932
wds:Q34742583-E8FC2FBA-E555-4C30-94CD-689F9A2A0E6E
wdt:P932
3067869